3 Month PHI PAD PoM Study

NCT02135848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Disease, Peripheral

Interventions

DRUG: GSK1278863
DRUG: Placebo

Sponsor

GlaxoSmithKline